Weaver H. Gaines has over 40 years of startup biotech and med device and business legal experience. Most recently he was CEO of OBMedical, a medical device company, which was sold to Philips Health in 2018. He is a Vietnam vet. Gaines received a BA from Dartmouth College and a JD from the University of Virginia, and began his career at the Wall Street law firm of Dewey Ballantine.

Dr. Euliano has spent the past 25 years leading teams developing medical devices and technology. He holds over 40 US patents and over 7 FDA-cleared devices. In addition, he has a long history in managing multi-disciplinary medical development teams.

Euliano holds a PhD in Signal Processing and Electrical Engineering, an MSEE in Electrical Engineering, and a BSE in Computer Science all from the University of Florida.

A serial entrepreneur, with 30 years progressive corporate finance and operations experience, Ramsey has played a key role in raising over $100 million, including several successful IPOs. As co-founder and Chief Financial Officer for OBMedical Company, she played a key role in forwarding a ground-breaking wireless fetal/maternal monitor for use in labor and delivery departments, leading to a successful sale to Philips Healthcare.

Dr. Abernathey is the CMO at Serodopa Therapeutics and Meridian Behavioral Healthcare, overseeing OTP, the detox unit, and addiction treatment, focusing on opioid addiction. He works extensively with PTSD patients. Previously, he was the Medical Director at Ology Bioservices and a faculty member at the University of Florida College of Medicine. Dr. Abernethy is a Major in the U.S. Army Reserve and a University of Florida Medical School graduate.

Over 35 years’ experience in Life sciences, with extensive experience with neuromodulation technology. At Cochlear Americas, he built the LA business, growing revenue by 30% annually. As CEO, he led Neuromonics (acquired by SoundVida) and Sophono (acquired by Medtronic). In addition, as EVP of the Americas/EMEA, he saw significant growth heading all activities for the Americas, Europe, Middle East and Africa, with a fivefold increase in sales.